Cite
HARVARD Citation
Iavarone, M. et al. (2019). Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation. American journal of transplantation. 19 (11), pp. 3176-3184. [Online].